Bank of America
NMTC icon

Bank of America’s NeuroOne Medical Technologies NMTC Stock Holding History

Bank of America’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-77
Closed -$351 – 6490
2025
Q4 		$351 Buy
77
+3
+4% +$14 ﹤0.01% 6619
2025
Q3 		$396 Buy
74
+2
+3% +$10 ﹤0.01% 7623
2025
Q2 		$292 Buy
72
+24
+50% +$89 ﹤0.01% 7775
2025
Q1 		$246 Buy
48
+10
+26% +$63 ﹤0.01% 7647
2024
Q4 		$188 Hold
38
– – ﹤0.01% 7602
2024
Q3 		$227 Buy
38
+2
+6% +$10 ﹤0.01% 7537
2024
Q2 		$173 Buy
+36
New +$226 ﹤0.01% 7588
2024
Q1 		– Sell
-5
Closed -$48 – 8044
2023
Q4 		$48 Sell
5
-12
-71% -$88 ﹤0.01% 7507
2023
Q3 		$89 Buy
+17
New +$114 ﹤0.01% 7474
2023
Q1 		– Sell
-6
Closed -$40 – 8124
2022
Q4 		$40 Buy
+6
New +$54 ﹤0.01% 7842

Other funds holding NMTC

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return

Bank of America's NMTC Position: Q1 2026 in Review

Bank of America sold out of NeuroOne Medical Technologies (NMTC) in Q1 2026, closing a stake of 77 shares — an estimated $351 sold.

Bank of America first reported a position in NMTC in Q4 2022 and held it in 10 quarters. The position peaked at $396 in Q3 2025. 32 funds tracked by Wall St. Rank hold NMTC as of Q1 2026.

  • Bank of America reported no remaining NeuroOne Medical Technologies position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 77 NeuroOne Medical Technologies shares in Q1 2026, an estimated $351.
  • Bank of America first reported a position in NeuroOne Medical Technologies in Q4 2022 and held it in 10 quarters.
  • Bank of America's NeuroOne Medical Technologies position peaked at $396 in Q3 2025.
  • 32 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.